Articles tagged with Analgesics
A study of nearly 81,000 women found that regular use of ibuprofen reduced breast cancer risk by 28%, while aspirin use reduced it by 22%. Both NSAIDs showed a significant effect in reducing the incidence of breast cancer, especially among high-risk groups.
Treatment with salicylic acid (SAL) induces activation of the S. aureus stress response gene sigB, downregulating virulence factors and reducing ability to adhere to host cells. This finding represents a new prospect for using aspirin as an adjunct therapy to combat Staphylococcus aureus infections.
A recent study by the American College of Emergency Physicians found no significant racial differences in the administration of pain medications to children, but did reveal regional variations. Children in the South and West received narcotics more frequently than those in other parts of the country.
In a multi-center, double-blind study, ENBREL 50 mg administered once weekly achieved an ACR 20 response in 50% of patients, compared to 19% in the placebo group. ENBREL also showed comparable improvement in HAQ and patient-reported measures of global status and pain.
A new blood test can detect heart attacks in just five minutes with a 99% accuracy rate, improving diagnosis and treatment outcomes. The test identifies two proteins associated with the earliest stages of a heart attack, reducing unnecessary hospital stays.
The study shows that aspirin is likely a better choice than ticlopidine for recurrent stroke prevention in African Americans, who face higher stroke risks. Aspirin is readily available and inexpensive, while ticlopidine has serious side effects and is more difficult to use.
A recent study published in Annals of Internal Medicine suggests that spinal manipulation, a key component of chiropractic care, is an effective and safer alternative to pharmaceuticals for treating back pain. The American Chiropractic Association applauds the findings, which align with its long-standing advocacy for evidence-based care.
A study by the University of Alberta has found that giving people drugs to treat back pain can improve performance. The research team led by Dr. Saifee Rashiq ran a randomized controlled trial where participants were injected with a strong narcotic painkiller and completed the Sorensen test, showing a significant increase in functional...
A study using camera pills found that people taking NSAIDs regularly are at increased risk of small intestinal mucosal ulceration and bleeding. The study, which used capsule endoscopy to visualize the entire small intestine, detected erosions in 62% of NSAID users compared to 5% of non-users.
A study conducted at Mt. Everest found that acetaminophen was as effective as ibuprofen in treating high-altitude headaches, with both medications providing similar levels of pain relief and reduced nausea. The results suggest that acetaminophen could be a safer alternative for patients suffering from high-altitude headache.
A study of 120 patients found that less than 3% required surgical treatment after CT-guided interventional procedures. The procedure was effective in reducing analgesic drug consumption and may be used as a complement to physical therapy.
A University of Toronto study estimates that pain pump programming errors could result in up to 667 deaths, with reporting rates ranging from 1.2% to 7.7%. The researchers recommend redesigning the control panel using human factors engineering techniques to reduce human error.
The CT1 is a small, wireless device providing pain relief with minimal side effects. It can be used for various conditions such as arthritis, minor cuts, and surgical procedures.
Women taking two or more NSAIDs per week for five to nine years reduced their breast cancer risk by 21-28%. Ibuprofen was found to be more effective than aspirin in preventing breast cancer. The study's findings suggest that COX-2 inhibition may play a role in limiting breast tumor growth.
Regular NSAID use for five to nine years reduces breast cancer risk by 21%, while ten-year use increases the reduction to 28%. The study enrolled 80,741 post-menopausal women with no reported history of cancer, other than non-melanoma skin cancer.
A study published in Diabetes Care found that alpha lipoic acid significantly improved symptoms of diabetic neuropathy, including a 5.7-point total symptom score improvement. The treatment had no unfavorable side effects and may be a promising lead for future research into the cause and prevention of diabetic neuropathy.
A single application of high-concentration capsaicin patches has been shown to provide significant long-term pain relief for patients with postherpetic neuralgia, a condition that often persists for years. The patch-based treatment avoids systemic side effects associated with traditional treatments.
Researchers found that high doses of acetaminophen (up to 8g/day) were quickly eliminated from the bloodstream, with no accumulation or liver damage. The study's findings suggest that consumers can safely take higher doses than recommended, but emphasize the importance of adhering to the standard daily limit.
A new study conducted in 33 Michigan hospitals shows significant improvements in the use of proven treatments and lifestyle counseling for heart attack patients. The study, led by researchers at the University of Michigan Cardiovascular Center, found that hospitals that implemented a system of reminders and checklists saw increases in ...
A nationwide study found that frovatriptan succinate prevented menstrually associated migraines (MAM) in as many as half the women evaluated. The drug significantly reduced MAM severity and duration, as well as patients' functional impairment and use of rescue medications.
Researchers found that using nonsteroidal anti-inflammatory drugs (NSAIDs) may help slow the progression of Alzheimer's disease. However, data suggests that low-dose aspirin use does not provide a significant protective effect against developing Alzheimer's.
A new study found that levorphanol's ability to reduce pain is comparable to tricyclic antidepressants and gabapentin, commonly used drugs for neuropathic pain treatment. High-dose treatment provided greater pain reduction without tolerance, but also led to more side effects and participant dropout.
A new study by McGill University found that redheaded women respond better to a painkilling drug due to a genetic variation in the Mc1r gene. This gene is associated with pigmentation and variants cause red hair and fair skin, leading to a heightened response to kappa-specific analgesics.
Researchers have developed a glycosylated enkephalin that appears promising in studies using mice, triggering behavior consistent with reduced addiction and fewer side effects than morphine. The compound interacts with both mu and delta receptors to increase analgesic strength while limiting narcotic side effects.
African Americans with chronic pain experience significantly more symptoms than whites when seeking treatment, including greater levels of pain, depression, and impairment. Economic factors also play a significant role in producing these disparities.
A study found that Keppra, when used in combination with conventional treatments, provided significant pain relief for multiple sclerosis (MS) patients. Over half of the participants showed marked improvement and continued treatment with Keppra.
A new study finds Keppra alleviates severe nerve pain in cancer patients by reducing VAS scores to 0-3 within 3-14 days, with a significant decrease in opioid use. The medication was well-tolerated and showed potential therapeutic benefits for further investigation.
A community study of 400 patients with various pain types found that Keppra was well-tolerated and provided significant pain relief. The medication was effective in treating a range of conditions, including migraine headaches, nerve pain, and diabetic pain.
According to Dr. Robert Kaniecki, a University of Pittsburgh neurologist, migraine headaches are often underdiagnosed, with over 50% of patients being mislabeled as having 'sinus headache' or 'tension headache'. This can lead to excessive prescriptions for antibiotics and decongestants, contributing to antibiotic resistance.
A randomized, double-blind study of over 1100 patients found that low-dose aspirin reduced the incidence of polyps by 19% and advanced lesions by more than 40%. Regular aspirin tablets also showed significant reductions in adenoma occurrence.
A major study shows that taking 325 milligrams of aspirin daily can reduce the risk of developing polyps in the colon by 35%, a significant step towards preventing colorectal cancer. The study involved over 100 medical centers and clinics across the US, with patients who had previously suffered from colorectal cancer.
A large randomized trial found that daily aspirin use reduced the incidence of adenomas and prolonged time to appearance in colon cancer patients, offering strong evidence for its protective properties.
A daily aspirin regimen was found to significantly reduce the occurrence of pre-cancerous polyps in patients with a history of colorectal cancer, lowering their risk by about one-third. Aspirin's protective effect also prevented the development of new adenomas and reduced the number of existing polyps.
A landmark analysis found that oxycodone was involved in only a small percentage of drug abuse deaths, with multiple drugs present in most cases. The study suggests that abusing opioids with other substances increases risk and calls for enhanced classification methods.
A study published in the American Association for the Advancement of Science suggests that estrogen levels influence women's ability to suppress pain. The researchers used PET scans to examine the brain's response to pain in individuals with different gender, hormone, and genetic profiles.
Researchers found baby aspirin to be less effective in reducing the risk of stroke compared to adult and coated formulas. The study suggests that age and gender play a role in a person's response to aspirin, with women being more effective than men.
Researchers found that combining ibuprofen with aspirin increased the risk of death from any cause and cardiovascular disease by 75% and 200%, respectively. Patients taking both medications also had a higher risk of bleeding from stomach ulcers.
A new study provides validated guidelines for emergency physicians to care for chest-pain patients using cocaine, improving treatment outcomes and reducing complications. The protocol divides patients into high-risk and low-risk categories, allowing doctors to determine which patients can be safely discharged home.
A Stanford study found a significant link between depression and chronic pain, suggesting that pain may guide doctors to effective treatments for depressed patients. The research also indicates that continuous pain increases the likelihood of major depressive disorder diagnosis.
A $1.4 million NIH-funded study will use genetically altered mice to find morphine-regulated genes that cause tolerance and dependence. The researchers aim to create better therapeutics and prevent dependence, with potential benefits for children born to drug-dependent mothers.
A new study by UT Southwestern researchers found that acetaminophen overdoses are the leading cause of acute liver failure in the US, affecting 39% of patients. The three-year study also revealed that most cases were unintentional and affected mostly women.
A meta-analysis of randomized trials confirms that aspirin significantly reduces first heart attack risk and combined cardiovascular events. The study supports recent guidelines recommending aspirin therapy for individuals with a 10% or greater 10-year coronary event risk.
A new study by the American Heart Association found that death rates are significantly lower in hospitals that follow established guidelines for treating heart attacks. The study examined adherence to clinical practice guidelines at 1,085 US hospitals and found that leading hospitals had a 50% higher rate of beta-blocker use and a 30% ...
A new study published in Obstetrics and Gynecology found that aspirin inhibited ovarian tumor cell growth by as much as 68 percent. Combining aspirin with a monoclonal antibody targeting the HER-2/neu protein resulted in an even greater suppression of growth, decreasing cancer cell growth by 84 percent.
A study of 75 patients found that postponing care for those with non-serious illnesses had comparable health outcomes to immediate care. Additionally, a new combination therapy for arthritis patients showed promise in reducing joint symptoms and improving function.
Patients receiving enzyme replacement therapy for a near-two-year period show improved pain levels and reduced organ damage. The treatment continues to be effective despite the presence of antibodies in some patients.
A study reveals a new mechanism in acetaminophen toxicity and suggests blocking the CAR receptor as a potential approach to treating liver damage. Researchers found that CAR plays a critical role in mediating acetaminophen's toxic effects, and a drug called androstanol shows promise in reversing this effect.
Researchers from Johns Hopkins University and National Institutes of Health found opioids to be highly effective in reducing pain in PHN patients, while causing no appreciable cognitive decline. The study's results provide convincing evidence for the use of opioids as an alternative treatment option for neuropathic pain.
The Mayo Clinic study highlights the effectiveness of opioids in relieving chronic lower back pain, despite controversy over misuse and potential drug dependence. The research emphasizes the need for careful patient selection and close monitoring to ensure safe treatment outcomes.
Researchers found that aspirin use did not decrease the effectiveness of ACE inhibitor therapy in patients. The combination of both treatments significantly reduced major vascular outcomes by 22%, producing substantial additional benefits for patients at high risk of events.
A double-blind, randomized controlled trial found that taking aspirin at bedtime significantly reduced the risk of preterm labor and preeclampsia in pregnant women with high blood pressure. The study also showed significant weight gains in babies born to mothers who took aspirin at night.
Research suggests that long-term use of nonsteroidal anti-inflammatory drugs (NSAIDs) may reduce the risk of Alzheimer's disease by up to 45% if started before the onset of dementia. Aspirin compounds and other medications showed similar protective effects, while recent or late use offered little protection.
Researchers from Leiden discovered that vitamins C and E can prevent breathing problems in patients after surgery by reducing the impact of sedatives and painkillers. The study found that stress and pain play a significant role in maintaining alertness, which may help counteract breathing issues.
Researchers found that low-dose aspirin changes the composition of arterial plaques, reducing cholesterol-rich cells and increasing collagen and smooth muscle cells. This shift in plaque composition is associated with reduced inflammation and lower risk of rupture.
A new compound, ajulemic acid, is being tested for its effectiveness in treating chronic pain, arthritis, and multiple sclerosis. Results from animal studies have shown promising results, and the compound has been found to be safe and effective with minimal side effects.
Newborn infants exhibit increased pain response after repeated painful procedures, learning to anticipate pain. The study supports efforts to decrease pain in infants undergoing medical procedures.
Panek and his research team have discovered a process that leads to an almost pure form of 'handed' tetrahydropyridine, a component found in many drugs. The molecule's unusual chemical properties can control a reaction's three-dimensional orientation.
A study of over 7 years found that women taking aspirin two to five times per week had a lower risk of pancreatic cancer compared to those not taking it. The researchers estimate that aspirin use might prevent up to 43% of pancreatic cancer cases in women who do not normally take aspirin.
A study examines the potential of pharmacogenomic testing to help drug-treatment centers select suitable treatment regimens for opiate-addicted patients. The research investigates genetic polymorphisms affecting opioid metabolism, aiming to improve pain management and drug-abuse treatment.
A combination therapy of aspirin and coumarin reduced artery re-closure after heart attacks by 45% in a clinical trial. The therapy also improved problem-free survival rates and reduced the incidence of second heart attacks, according to researchers from the American Heart Association.